Back to results
US 2006/0134108 A1Published application
Method for retarding or precluding Alzheimer's dementia
OwnerGeorge Jackowski, Shirley Fureszinventors
Life of this patent
Estimating the term…
Abstract
A method for treating a condition related to the development of Alzheimer's disease (AD) is disclosed. The method involves the removal of circulating autoantibodies of a biochemical marker or markers, specifically human glial fibrillary acidic protein (GFAP) and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), from the sera of a patient in an amount effective to reduce or eliminate phagocytosis of astrocytic cells. The invention further includes a process of immune system modulation effective for autoantibody removal.
Claims1
A process for retarding phagocytosis of astrocytic cells comprising:
- removing autoantibodies against glial fibrillary acidic protein (GFAP) from a body fluid;
- whereby removing said autoantibodies from said body fluid retards phagocytosis of astrocytic cells.
Dependencies are inferred from the claim text.